Initial experience from a renal genetics clinic demonstrates a distinct role in patient management

por Thomas, Christie P., Freese, Margaret E., Ounda, Agnes, Jetton, Jennifer G., Holida, Myrl, Noureddine, Lama, Smith, Richard J.
Publicado 2020

Correction: Initial experience from a renal genetics clinic demonstrates a distinct role in patient management

por Thomas, Christie P., Freese, Margaret E., Ounda, Agnes, Jetton, Jennifer G., Holida, Myrl, Noureddine, Lama, Smith, Richard J.
Publicado 2020

Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease

por Goláň, Lubor, Goker-Alpan, Ozlem, Holida, Myrl, Kantola, Ikka, Klopotowski, Mariusz, Kuusisto, Johanna, Linhart, Aleš, Musial, Jacek, Nicholls, Kathleen, Gonzalez-Rodriguez, Derlis, Sharma, Reena, Vujkovac, Bojan, Chang, Peter, Wijatyk, Anna
Publicado 2015

Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused Agalsidase

por Warnock, David G., Bichet, Daniel G., Holida, Myrl, Goker-Alpan, Ozlem, Nicholls, Kathy, Thomas, Mark, Eyskens, Francois, Shankar, Suma, Adera, Mathews, Sitaraman, Sheela, Khanna, Richie, Flanagan, John J., Wustman, Brandon A., Barth, Jay, Barlow, Carrolee, Valenzano, Kenneth J., Lockhart, David J., Boudes, Pol, Johnson, Franklin K.
Publicado 2015